Is low-dose ciclosporin an effective treatment for membranous nephropathy with nephrotic syndrome?

Nature Clinical Practice Nephrology

Volumn 3, Issue 4, 2007, Pages 190-191

  Mathieson, Peter W ^a,b,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYCLOSPORIN;

ALBUMIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NEPHROTIC SYNDROME; NOTE; PRIORITY JOURNAL; PROTEINURIA; RECURRENCE RISK; RELAPSE; REMISSION; RISK REDUCTION;

EID: 33947657001     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0436     Document Type: Note

References (5)

1. Schieppati A et al. (2004) Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. The Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004293.pub2. [doi:10.1002/14651858.CD004293. pub2.]
2. Mathieson P (1998) Treating progressive and indolent MGN. QJM 91: 167
3. Mathieson PW (2000) Cyclosporin: nephro-protective as well as nephrotoxic? Clin Exp Immunol 121: 179-180
4. Cattran DC et al. (2001) Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484-1490
5. Ronco P and Debiec H (2006) Molecular dissection of target antigens and nephritogenic antibodies in membranous nephropathy: towards epitope-driven therapies. J Am Soc Nephrol 17: 1772-1774